ENTITY

Alaunos Therapeutics (TCRT US)

1
Analysis
Health CareUnited States
Alaunos Therapeutics Inc. operates as a clinical stage cellular immuno-oncology company. The Company focuses on the treatment of solid tumors through adoptive TCR-T cell therapy. Alaunos Therapeutics serves customers worldwide.
more
Refresh
bullishMedgenics Inc
02 Dec 2016 13:01

Actionable Idea: Medgenics: Upcoming Catalyst, Recent Insider Buying, Huge Potential Market in ADHD.

We took another look at the design of the on-going phase 2/3 clinical trial for Medgenics Inc (MDGN US) NFC-1, to treat adolescents with attention...

No more insights
x